# Firefly Neuroscience, Inc.: overview AIFF · Nasdaq · CIK 803578 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/aiff.md) · [Financials](/companies/aiff/financials.md) · [Filings](/companies/aiff/filings.md) · [Insiders](/companies/aiff/insiders.md) Latest reported revenue: [$514.0k](/filings/0001437749-26-026822.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:Revenues, accession 0001437749-26-026822). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [33.0](/filings/0001213900-25-108474.md) | [53.0 d](/filings/0001437749-26-010500.md) | [43.0](/filings/0001437749-26-016501.md) | [299](/filings/0001437749-26-026822.md) | [388](/filings/0001213900-25-108474.md) | [412 d](/filings/0001437749-26-010500.md) | [485](/filings/0001437749-26-016501.md) | [514](/filings/0001437749-26-026822.md) | | Gross margin | % | [100.0%](/filings/0001213900-25-108474.md) | [100.0% d](/filings/0001437749-26-010500.md) | [100.0%](/filings/0001437749-26-016501.md) | [91.6%](/filings/0001437749-26-026822.md) | [37.6%](/filings/0001213900-25-108474.md) | [44.2% d](/filings/0001437749-26-010500.md) | [45.6%](/filings/0001437749-26-016501.md) | [49.2%](/filings/0001437749-26-026822.md) | | Operating margin | % | [(12933.3%)](/filings/0001213900-25-108474.md) | [(6483.0%) d](/filings/0001437749-26-010500.md) | [(4802.3%)](/filings/0001437749-26-016501.md) | [(546.5%)](/filings/0001437749-26-026822.md) | [(684.5%)](/filings/0001213900-25-108474.md) | [(607.0%) d](/filings/0001437749-26-010500.md) | [(414.4%)](/filings/0001437749-26-016501.md) | [(384.0%)](/filings/0001437749-26-026822.md) | | Net margin | % | [(12997.0%)](/filings/0001213900-25-108474.md) | [(7141.5%) d](/filings/0001437749-26-010500.md) | [(30069.8%)](/filings/0001437749-26-026822.md) | [(613.0%)](/filings/0001437749-26-026822.md) | [(680.2%)](/filings/0001213900-25-108474.md) | [(601.9%) d](/filings/0001437749-26-010500.md) | [(413.2%)](/filings/0001437749-26-026822.md) | [(386.0%)](/filings/0001437749-26-026822.md) | | Diluted EPS | $ per share | [(0.61)](/filings/0001213900-25-108474.md) | not reported | not reported | not reported | [(0.20)](/filings/0001213900-25-108474.md) | not reported | not reported | not reported | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [15.0](/filings/0001437749-23-010426.md) | [12.0](/filings/0001437749-23-010426.md) | [0.5](/filings/0001437749-25-010818.md) | [0.1](/filings/0001437749-26-010500.md) | [1.1](/filings/0001437749-26-010500.md) | | Gross margin | % | [24.1%](/filings/0001437749-23-010426.md) | [23.8%](/filings/0001437749-24-008626.md) | [525.0%](/filings/0001437749-24-008626.md) | [100.0%](/filings/0001437749-26-010500.md) | [56.5%](/filings/0001437749-26-010500.md) | | Operating margin | % | [(17.5%)](/filings/0001437749-23-010426.md) | [(45.1%)](/filings/0001437749-24-008626.md) | [(618.1%)](/filings/0001437749-25-010818.md) | [(9309.3%)](/filings/0001437749-26-010500.md) | [(775.5%)](/filings/0001437749-26-010500.md) | | Net margin | % | [(7.5%)](/filings/0001437749-23-010426.md) | [(147.7%)](/filings/0001437749-24-008626.md) | [(522.7%)](/filings/0001437749-25-010818.md) | [(9685.2%)](/filings/0001437749-26-010500.md) | [(1741.0%)](/filings/0001437749-26-010500.md) | | Diluted EPS | $ per share | [(0.09)](/filings/0001437749-22-008763.md) | not reported | not reported | not reported | not reported | | Free cash flow | $m | [(0.8)](/filings/0001437749-23-010426.md) | [(6.5)](/filings/0001437749-24-008626.md) | [(2.2)](/filings/0001437749-25-010818.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/aiff/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Murchinson Ltd.](/funds/1838556.md) | 2026-06-30 | $786.5k | 650,000 | | New +650,000 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $226.5k | 187,168 | | Added +17,806 | | [BOOTHBAY FUND MANAGEMENT, LLC](/funds/1549230.md) | 2026-06-30 | $216.3k | 178,750 | | New +178,750 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $147.1k | 121,522 | | Reduced −34,786 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $135.4k | 111,910 | | Unchanged | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $82.1k | 67,829 | | Reduced −112,392 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $71.5k | 59,119 | | Reduced −73,076 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $61.7k | 50,993 | | Unchanged | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $56.0k | 46,299 | | Unchanged | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $40.5k | 33,494 | | Added +17,730 | ## Recent filings [All 511 filings](/companies/aiff/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-14 | 16:30 ET | [8-K](/filings/0001213900-26-099733.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-099733 | | 2026-08-11 | 17:50 ET | [10-Q](/filings/0001437749-26-026822.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026822 | | 2026-08-07 | 16:30 ET | [8-K](/filings/0001213900-26-086720.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-086720 | | 2026-07-09 | 07:06 ET | [DEF 14A](/filings/0001140361-26-028044.md) | Proxy statement, period 2026-08-05 | 0001140361-26-028044 | | 2026-06-26 | 16:30 ET | [8-K](/filings/0001213900-26-072645.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-072645 | | 2026-06-22 | 16:15 ET | [8-K](/filings/0001213900-26-070626.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-070626 | | 2026-05-13 | 18:23 ET | [10-Q](/filings/0001437749-26-016501.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016501 | | 2026-05-12 | 16:30 ET | [8-K](/filings/0001213900-26-055110.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-055110 | | 2026-04-22 | 16:30 ET | [8-K](/filings/0001213900-26-046627.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-046627 | | 2026-03-31 | 07:38 ET | [10-K](/filings/0001437749-26-010500.md) | Annual report, period 2025-12-31 | 0001437749-26-010500 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-010500.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/d0bba1df-b90b-4a31-9451-f969311f8afb) ## About the filer - CIK: 803578 - Tickers: AIFF - Exchange: Nasdaq - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.